ABM-168

· ABM Therapeutics Corporation

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ABM-168, covering 2024-12-06 to 2024-12-06. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Effectiveness of ABM-168 in Adults with Advanced Solid Tumors. [Phase 1]